NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test

Journal of Psychopharmacology

Volumn 24, Issue 4, 2010, Pages 585-594

  Ghasemi, M ^a   Raza, M ^b   Dehpour, A R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Depression; Forced swimming test; Ifenprodil; Ketamine; Lithium; Mice; MK 801; N methyl D aspartate receptor antagonists; NMDA

Indexed keywords

DIZOCILPINE; IFENPRODIL; KETAMINE; LITHIUM CHLORIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG POTENTIATION; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL;

EID: 77950377037     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109104845     Document Type: Article

References (109)

1. Almeida, RC, Felisbino, CS, Lopez, MG, Rodrigues, AL, Gabilan, NH (2006 a) Evidence for the involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav Brain Res 168: 318-322.
2. Almeida, RC, Souza, DG, Soletti, RC, Lopez, MG, Rodrigues, AL, Gabilan, NH (2006 b) Involvement of PKA, MAPK/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice. Neurosci Lett 395: 93-97.
3. Antonelli, T., Ferioli, V., Lo Gallo, G., Tomasini, MC, Fernandez, M., OConnor, WT, et al. (2000) Differential effects of acute and short-term lithium administration on dialysate glutamate and GABA levels in the frontal cortex of the conscious rat. Synapse 38: 355-362.
4. Baron, M., Gershon, ES, Rudy, V., Jonas, WZ, Buchsbaum, M. (1975) Lithium carbonate response in depression. Prediction by unipolar/ bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 32: 1107-1111.
5. Basselin, M., Chang, L., Bell, JM, Rapoport, SI (2006) Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31: 1659-1674. (Pubitemid 44106697)
6. Bauer, M., Alda, M., Priller, J., Young, LT (2003) Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry 36 (Suppl. 3). S250 - S254. (Pubitemid 38085143)
7. Bauer, M., Bschor, T., Kunz, D., Berghofer, A., Strohle, A., Muller-Oerlinghausen, B. (2000) Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 157: 1429-1435.
8. Bauer, MS, Mitchner, L. (2004) What is a "mood stabilizer"? An evidence-based response. Am J Psychiatry 161: 3-18. (Pubitemid 38419301)
9. Berman, RM, Cappiello, A., Anand, A., Oren, DA, Heninger, GR, Charney, DS, et al. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351-354. (Pubitemid 30109248)
10. Bersudsky, Y., Shaldubina, A., Belmaker, RH (2007) Lithiums effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav Pharmacol 18: 77-80. (Pubitemid 46103286)
11. Bourin, M., Prica, C. (2007) The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders. Neurosci Biobehav Rev 31: 963-975. (Pubitemid 47285346)
12. Boyce-Rustay, JM, Holmes, A. (2006) Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 31: 2405-2414. (Pubitemid 44607058)
13. Cade, JF (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2: 349-352.
14. Clinton, SM, Meador-Woodruff, JH (2004) Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder. Neuropsychopharmacology 29: 1353-1362.
15. Crane, GE (1959) Cyloserine as an antidepressant agent. Am J Psychiatry 115: 1025-1026.
16. Crane, GE (1961) The psychotropic effects of cycloserine: a new use for an antibiotic. Compr Psychiatry 2: 51-59.
17. Cryan, JF, Markou, A., Lucki, I. (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23: 238-245. (Pubitemid 34465544)
18. Cryns, K., Shamir, A., Shapiro, J., Daneels, G., Goris, I., Van Craenendonck, H., et al. (2007) Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice. Neuropsychopharmacology 32: 881-891. (Pubitemid 46426173)
19. Dixon, JF, Hokin, LE (1998) Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci U S A 95: 8363-8368.
20. Dixon, JF, Los, GV, Hokin, LE (1994) Lithium stimulates glutamate "release" and inositol 1,4,5-trisphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices. Proc Natl Acad Sci U S A 91: 8358-8362. (Pubitemid 24273663)
21. Esplugues, JV (2002) NO as a signalling molecule in the nervous system. Br J Pharmacol 135: 1079-1095.
22. Faria, MS, Teixeira, NA (1993) Reversal of learned helplessness by chronic lithium treatment at a prophylactic level. Braz J Med Biol Res 26: 1201-1212.
23. Ferguson, JM, Shingleton, RN (2007) An open-label, flexible-dose study of memantine in major depressive disorder. Clin Neuropharmacol 30: 136-144. (Pubitemid 46871863)
24. Freeman, MP, Freeman, SA (2006) Lithium: clinical considerations in internal medicine. Am J Med 119: 478-481. (Pubitemid 43795184)
25. Garcia, LS, Comim, CM, Valvassori, SS, Reus, GZ, Barbosa, LM, Andreazza, AC, et al. (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32: 140-144.
26. Ghasemi, M., Sadeghipour, H., Mosleh, A., Sadeghipour, HR, Mani, AR, Dehpour, AR (2008) Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol 18: 323-332. (Pubitemid 351381351)
27. Goforth, HW, Holsinger, T. (2007) Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. J ECT 23: 23-25. (Pubitemid 46673528)
28. Goodwin, FK, Murphy, DL, Dunner, DL, Bunney Jr., WE (1972) Lithium response in unipolar versus bipolar depression. Am J Psychiatry 129: 44-47.
29. Gould, TD, Einat, H., ODonnell, KC, Picchini, AM, Schloesser, RJ, Manji, HK (2007) Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 32: 2173-2183. (Pubitemid 47417687)
30. Gould, TD, ODonnell, KC, Dow, ER, Du, J., Chen, G., Manji, HK (2008) Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 54: 577-587.
31. Hascoet, M., Bourin, M., Khimake, S. (1994) Additive effect of lithium and clonidine with 5-HT1A agonists in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 18: 381-396. (Pubitemid 24102920)
32. Hashimoto, R., Hough, C., Nakazawa, T., Yamamoto, T., Chuang, DM (2002) Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem 80: 589-597. (Pubitemid 34809967)
33. Hata, T., Itoh, E., Nishikawa, H. (1995) Behavioral characteristics of SART-stressed mice in the forced swim test and drug action. Pharmacol Biochem Behav 51: 849-853.
34. Heninger, GR, Charney, DS, Sternberg, DE (1983) Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression. Arch Gen Psychiatry 40: 1335-1342.
35. Hokin, LE, Dixon, JF, Los, GV (1996) A novel action of lithium: stimulation of glutamate release and inositol 1,4,5 trisphosphate accumulation via activation of the N-methyl D-aspartate receptor in monkey and mouse cerebral cortex slices. Adv Enzyme Regul 36: 229-244.
36. Huber, TJ, Dietrich, DE, Emrich, HM (1999) Possible use of amantadine in depression. Pharmacopsychiatry 32: 47-55.
37. Johnson, G. (1974) Antidepressant effect of lithium. Compr Psychiatry 15: 43-47.
38. Jope, RS (1999) A bimodal model of the mechanism of action of lithium. Mol Psychiatry 4: 21-25. (Pubitemid 29050196)
39. Jope, RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24: 441-443.
40. Kaster, MP, Ferreira, PK, Santos, AR, Rodrigues, AL (2005) Effects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res 165: 204-209.
41. Kelly, JP, Wrynn, AS, Leonard, BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74: 299-316. (Pubitemid 27425352)
42. Kitamura, Y., Araki, H., Gomita, Y. (2002) Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav 71: 63-69. (Pubitemid 34102464)
43. Kleindienst, N., Greil, W. (2003) Lithium in the long-term treatment of bipolar disorders. Eur Arch Psychiatry Clin Neurosci 253: 120-125. (Pubitemid 37205470)
44. Kofman, O., Levin, U., Alpert, C. (1995) Lithium attenuates hypokinesia induced by immobilization stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 19: 1081-1090.
45. Kos, T., Popik, P. (2005) A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice. Behav Pharmacol 16: 155-161. (Pubitemid 40695004)
46. Kudoh, A., Takahira, Y., Katagai, H., Takazawa, T. (2002) Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95: 114-118 (table of contents). (Pubitemid 34705563)
47. Law, AJ, Deakin, JF (2001) Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 12: 2971-2974.
48. Layer, RT, Popik, P., Olds, T., Skolnick, P. (1995) Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav 52: 621-627.
49. Li, R., el- Mallakh, RS, Harrison, L., Changaris, DG, Levy, RS (1997) Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Mol Chem Neuropathol 31: 65-72. (Pubitemid 27328637)
50. Liebrenz, M., Borgeat, A., Leisinger, R., Stohler, R. (2007 a) Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med Wkly 137: 234-236. (Pubitemid 46814243)
51. Liebrenz, M., Stohler, R., Borgeat, A. (2007 b) Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression. World J Biol Psychiatry: 1-4 [Epub ahead of print].
52. Lucki, I., Dalvi, A., Mayorga, AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155: 315-322.
53. Ma, J., Zhang, GY (2003) Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci Lett 348: 185-189.
54. Ma, J., Zhang, GY, Liu, Y., Yan, JZ, Hao, ZB (2004) Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia. Neurosci Res 49: 357-362.
55. Maeng, S., Zarate Jr., CA (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9: 467-474.
56. Maj, J., Rogoz, Z., Skuza, G. (1992 a) The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Pol J Pharmacol Pharm 44: 217-226.
57. Maj, J., Rogoz, Z., Skuza, G., Sowinska, H. (1992 b) The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol J Pharmacol Pharm 44: 337-346.
58. Maj, J., Rogoz, Z., Skuza, G., Sowinska, H. (1992 c) Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol 2: 37-41.
59. Meloni, D., Gambarana, C., De Montis, MG, Dal Pra, P., Taddei, I., Tagliamonte, A. (1993) Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats. Pharmacol Biochem Behav 46: 423-426.
60. Mendels, J., Secunda, SK, Dyson, WL (1972) A controlled study of the antidepressant effects of lithium carbonate. Arch Gen Psychiatry 26: 154-157.
61. Moryl, E., Danysz, W., Quack, G. (1993) Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol Toxicol 72: 394-397.
62. Muhonen, LH, Lonnqvist, J., Juva, K., Alho, H. (2008) Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry 69: 392-399.
63. Mundo, E., Tharmalingham, S., Neves-Pereira, M., Dalton, EJ, Macciardi, F., Parikh, SV, et al. (2003) Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry 8: 241-245. (Pubitemid 36315234)
64. Munoz, C., Yulan, N., Achaval, V., Appiani, F., Carroll, BT (2008) Memantine in major depression with catatonic features. J Neuropsychiatry Clin Neurosci 20: 119-120. (Pubitemid 351295051)
65. Nixon, MK, Hascoet, M., Bourin, M., Colombel, MC (1994) Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl) 115: 59-64. (Pubitemid 24207762)
66. Nonaka, S., Chuang, DM (1998) Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 9: 2081-2084. (Pubitemid 28300570)
67. Nonaka, S., Hough, CJ, Chuang, DM (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A 95: 2642-2647. (Pubitemid 28145996)
68. Nowak, G., Ordway, GA, Paul, IA (1995) Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675: 157-164.
69. OBrien, WT, Harper, AD, Jove, F., Woodgett, JR, Maretto, S., Piccolo, S., et al. (2004) Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24: 6791-6798. (Pubitemid 38993901)
70. Ostroff, R., Gonzales, M., Sanacora, G. (2005) Antidepressant effect of ketamine during ECT. Am J Psychiatry 162: 1385-1386.
71. Panconi, E., Roux, J., Altenbaumer, M., Hampe, S., Porsolt, RD (1993) MK-801 and enantiomers: potential antidepressants or false positives in classical screening models ? Pharmacol Biochem Behav 46: 15-20. (Pubitemid 23283300)
72. Papp, M., Moryl, E. (1993) New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors. Pol J Pharmacol 45: 549-553. (Pubitemid 24097651)
73. Papp, M., Moryl, E. (1994) Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur J Pharmacol 263: 1-7. (Pubitemid 24290246)
74. Papp, M., Moryl, E. (1996) Antidepressant-like effects of 1-amino-cyclopropanecarboxylic acid and D-cycloserine in an animal model of depression. Eur J Pharmacol 316: 145-151. (Pubitemid 27008144)
75. Paul, IA, Nowak, G., Layer, RT, Popik, P., Skolnick, P. (1994) Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 269: 95-102. (Pubitemid 24143240)
76. Paul, IA, Skolnick, P. (2003) Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003: 250-272. (Pubitemid 38083061)
77. Petrie, RX, Reid, IC, Stewart, CA (2000) The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review. Pharmacol Ther 87: 11-25.
78. Poleszak, E., WlaÅ°, P., K™dzierska, E., Nieoczym, D., Wróbel, A., Fidecka, S., et al. (2007) NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacol Biochem Behav 88: 158-164. (Pubitemid 350115999)
79. Porsolt, RD, Bertin, A., Jalfre, M. (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327-336. (Pubitemid 8225714)
80. Przegalinski, E., Tatarczynska, E., Deren-Wesolek, A., Chojnacka-Wojcik, E. (1997) Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist. Neuropharmacology 36: 31-37. (Pubitemid 27115840)
81. Quiroz, JA, Gould, TD, Manji, HK (2004) Molecular effects of lithium. Mol Interv 4: 259-272.
82. Redmond, AM, Kelly, JP, Leonard, BE (1997) Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacol Biochem Behav 58: 355-359.
83. Redrobe, JP, Bourin, M. (1999 a) The effect of lithium administration in animal models of depression: a short review. Fundam Clin Pharmacol 13: 293-299. (Pubitemid 32260275)
84. Redrobe, JP, Bourin, M. (1999 b) Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology (Berl) 141: 370-377. (Pubitemid 29190005)
85. Rogoz, Z., Skuza, G., Daniel, WA, Wojcikowski, J., Dudek, D., Wrobel, A. (2007) Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression. Pharmacol Rep 59: 778-784. (Pubitemid 351586572)
86. Rosa, AO, Lin, J., Calixto, JB, Santos, AR, Rodrigues, AL (2003) Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144: 87-93. (Pubitemid 37011169)
87. Scarr, E., Pavey, G., Sundram, S., MacKinnon, A., Dean, B. (2003) Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord 5: 257-264. (Pubitemid 37009889)
88. Schou, M. (2001) Lithium treatment at 52. J Affect Disord 67: 21-32. (Pubitemid 34183334)
89. Shaldubina, A., Johanson, RA, OBrien, WT, Buccafusca, R., Agam, G., Belmaker, RH, et al. (2006) SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior. Mol Genet Metab 88: 384-388. (Pubitemid 44107766)
90. Sherman, AD, Petty, F. (1980) Neurochemical basis of the action of antidepressants on learned helplessness. Behav Neural Biol 30: 119-134. (Pubitemid 11177645)
91. Silva, R., Mesquita, AR, Bessa, J., Sousa, JC, Sotiropoulos, I., Leao, P., et al. (2008) Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 152: 656-669.
92. Soares, JC, Gershon, S. (1998) The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 19: 167-182. (Pubitemid 28302573)
93. Song, C., Killeen, AA, Leonard, BE (1994) Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride. Neuropsychobiology 30: 24-28. (Pubitemid 24211369)
94. Stryjer, R., Strous, RD, Shaked, G., Bar, F., Feldman, B., Kotler, M., et al. (2003) Amantadine as augmentation therapy in the management of treatment-resistant depression. Int Clin Psychopharmacol 18: 93-96. (Pubitemid 36343978)
95. Teixeira, NA, Pereira, DG, Hermini, AH (1995) Chronic but not acute Li+ treatment prevents behavioral depression in rats. Braz J Med Biol Res 28: 1003-1007.
96. Tomasiewicz, HC, Mague, SD, Cohen, BM, Carlezon Jr., WA (2006) Behavioral effects of short-term administration of lithium and valproic acid in rats. Brain Res 1093: 83-94. (Pubitemid 43946407)
97. Toro, C., Deakin, JF (2005) NMDA receptor subunit NRI and post-synaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 80: 323-330. (Pubitemid 41713658)
98. Trullas, R., Folio, T., Young, A., Miller, R., Boje, K., Skolnick, P. (1991) 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur J Pharmacol 203: 379-385.
99. Trullas, R., Skolnick, P. (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185: 1-10. (Pubitemid 20254891)
100. van Riezen, H., Schnieden, H., Wren, AF (1977) Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs. Br J Pharmacol 60: 521-528. (Pubitemid 8149537)
101. Wegener, G., Bandpey, Z., Heiberg, IL, Mork, A., Rosenberg, R. (2003) Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat. Psychopharmacology (Berl) 166: 188-194. (Pubitemid 36313127)
102. Woo, TU, Walsh, JP, Benes, FM (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61: 649-657.
103. Worrall, EP, Moody, JP, Peet, M., Dick, P., Smith, A., Chambers, C., et al. (1979) Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry 135: 255-262. (Pubitemid 9244810)
104. Yamamoto, T., Araki, H., Abe, Y., Ueki, S. (1985) Effects of chronic LiCl and RbCl on muricide induced by midbrain raphe lesions in rats. Pharmacol Biochem Behav 22: 559-563. (Pubitemid 15108233)
105. Yildiz-Yesiloglu, A., Ankerst, DP (2006) Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry 30: 969-995. (Pubitemid 43928209)
106. Yilmaz, A., Schulz, D., Aksoy, A., Canbeyli, R. (2002) Prolonged effect of an anesthetic dose of ketamine on behavioral despair. Pharmacol Biochem Behav 71: 341-344. (Pubitemid 34102498)
107. Zamoshchina, TA, Saratikov, AS (1997) [ Efficacy of the lithium compound with prolonged action during "reserpine depression ".] Eksp Klin Farmakol 60: 27-30.
108. Zamoshchina, TA, Saratikov, AS, Maslov, LN, Matveenko, AV (1997) [The effect of lithium chloride on the desynchronization of "reserpine-induced depression".] Eksp Klin Farmakol 60: 3-6.
109. Zarate Jr, CA, Singh, JB, Carlson, PJ, Brutsche, NE, Ameli, R., Luckenbaugh, DA, et al. (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864. (Pubitemid 44188478)